Meridian Management’s Johnson & Johnson JNJ Stock Holding History

Meridian Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,451	Closed	-$210K	–	88
2024 Q4	$210K	Buy	+1,451	New	+$225K	0.06%	96
2022 Q2	–	Sell	-1,230	Closed	-$218K	–	80
2022 Q1	$218K	Buy	+1,230	New	+$209K	0.07%	81
2021 Q3	–	Sell	-1,230	Closed	-$203K	–	79
2021 Q2	$203K	Buy	+1,230	New	+$204K	0.06%	80

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Meridian Management's JNJ Position: Q1 2025 in Review

Meridian Management sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 1,451 shares — an estimated $210K sold.

Meridian Management first reported a position in JNJ in Q2 2021 and held it in 3 quarters. The position peaked at $218K in Q1 2022. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

Meridian Management reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
Meridian Management sold 1,451 Johnson & Johnson shares in Q1 2025, an estimated $210K.
Meridian Management first reported a position in Johnson & Johnson in Q2 2021 and held it in 3 quarters.
Meridian Management's Johnson & Johnson position peaked at $218K in Q1 2022.
4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Meridian Management's 13F filing for Q1 2025, filed 7 May 2025.